NextCure, Inc. Common Stock NXTC

$6.65 -13.75% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 Insider transaction 2026-08-12 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 PRIMARY DOCUMENT 2026-08-03 View →
4 PRIMARY DOCUMENT 2026-07-29 View →
8-K FORM 8-K 2026-07-14 View →
8-K 8-K 2026-06-25 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
8-K 8-K 2026-06-01 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A FORM DEF 14A 2026-04-24 View →
10-K 10-K 2026-03-05 View →
8-K 8-K 2026-03-05 View →
4 FORM 4 2026-02-03 View →
4 FORM 4 2026-02-03 View →
4 FORM 4 2026-02-03 View →
4 FORM 4 2026-02-03 View →
4 FORM 4 2026-02-03 View →
4 FORM 4 2026-02-03 View →
8-K 8-K 2026-01-23 View →
8-K FORM 8-K 2025-12-19 View →
424B5 424B5 2025-12-19 View →
S-3 S-3 2025-11-26 View →
8-K 8-K 2025-11-17 View →
10-Q 10-Q 2025-11-05 View →
8-K 8-K 2025-11-05 View →
8-K 8-K 2025-08-25 View →
10-Q 10-Q 2025-08-07 View →
8-K 8-K 2025-08-07 View →
S-3 S-3 2025-07-18 View →
8-K 8-K 2025-07-14 View →
8-K 8-K 2025-07-10 View →
4 Insider transaction 2025-06-24 View →
4 Insider transaction 2025-06-24 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$6.65
Market Cap
$35.29 million
52-Week Range
$1.55 – $15.74
Average Volume
4.36 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.